AAAAAA
Results: 1-25/29
Authors:
AGULLO JLR
SUAREZ A
LADERO JM
LOPEZALONSO G
PICAZO JJ
DIAZRUBIO M
Citation: Jlr. Agullo et al., HEPATITIS-G VIRUS-INFECTION IN SPANISH PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Liver, 18(4), 1998, pp. 255-258
Authors:
LADERO JM
GARCIAAGUNDEZ JA
BENITEZ J
Citation: Jm. Ladero et al., ENZYMATIC POLYMORPHISMS AND LUNG-CANCER, Medicina Clinica, 111(12), 1998, pp. 465-470
Authors:
AGUNDEZ JAG
MARTINEZ C
OLIVERA M
GALLARDO L
LADERO JM
ROSADO C
PRADOS J
RODRIGUEZMOLINA J
RESEL L
BENITEZ J
Citation: Jag. Agundez et al., EXPRESSION IN HUMAN PROSTATE OF DRUG-METABOLIZING AND CARCINOGEN-METABOLIZING ENZYMES - ASSOCIATION WITH PROSTATE-CANCER RISK, British Journal of Cancer, 78(10), 1998, pp. 1361-1367
Authors:
DIAZGUTIERREZ FL
LADERO JM
DIAZRUBIO M
Citation: Fl. Diazgutierrez et al., ACARBOSE-INDUCED ACUTE HEPATITIS, The American journal of gastroenterology, 93(3), 1998, pp. 481-481
Authors:
GULLSTEN H
AGUNDEZ JAG
BENITEZ J
LAARA E
LADERO JM
DIAZRUBIO M
FERNANDEZSALGUERO P
GONZALEZ F
RAUTIO A
PELKONEN O
RAUNIO H
Citation: H. Gullsten et al., CYP2A6 GENE POLYMORPHISM AND RISK OF LIVER-CANCER AND CIRRHOSIS, Pharmacogenetics, 7(3), 1997, pp. 247-250
Authors:
AGUNDEZ JAG
JIMENEZJIMENEZ FJ
TEJEDA R
LEDESMA MC
ORTIPAREJA M
GASALLA T
MOLINA JA
RUIZ J
CORIA F
DUARTE J
VAZQUEZ A
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., CYP2D6 POLYMORPHISM IS NOT ASSOCIATED WITH ESSENTIAL TREMOR, European neurology, 38(2), 1997, pp. 99-104
Authors:
AGUNDEZ JAG
RODRIGUEZ I
OLIVERA M
LADERO JM
GARCIA MA
RIBERA JM
BENITEZ J
Citation: Jag. Agundez et al., CYP2D6, NAT2 AND CYP2E1 GENETIC POLYMORPHISMS IN NONAGENARIANS, Age and ageing, 26(2), 1997, pp. 147-151
Authors:
AGUNDEZ JAG
OLIVERA M
LADERO JM
RODRIGUEZLESCURE A
LEDESMA MC
DIAZRUBIO M
MEYER UA
BENITEZ J
Citation: Jag. Agundez et al., INCREASED RISK FOR HEPATOCELLULAR-CARCINOMA IN NAT2-SLOW ACETYLATORS AND CYP2D6-RAPID METABOLIZERS, Pharmacogenetics, 6(6), 1996, pp. 501-512
Authors:
AGUNDEZ JAG
OLIVERA M
MARTINEZ C
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., IDENTIFICATION AND PREVALENCE STUDY OF 17 ALLELIC VARIANTS OF THE HUMAN NAT2 GENE IN A WHITE-POPULATION, Pharmacogenetics, 6(5), 1996, pp. 423-428
Authors:
LADONA MG
ABILDUA RE
LADERO JM
ROMAN JM
PLAZA MA
AGUNDEZ JAG
MUNOZ JJ
BENITEZ J
Citation: Mg. Ladona et al., CYP2D6 GENOTYPES IN SPANISH WOMEN WITH BREAST-CANCER, Cancer letters, 99(1), 1996, pp. 23-28
Authors:
LARRUBIA JR
LADERO JM
MENDOZA JL
MORILLAS JD
DIAZRUBIO M
Citation: Jr. Larrubia et al., THE ROLE OF SONOGRAPHY IN THE EARLY DIAGNOSIS OF BILIOPANCREATIC ASCARIS INFESTATION, Journal of clinical gastroenterology, 22(1), 1996, pp. 48-50
Authors:
LADERO JM
Citation: Jm. Ladero, EMPATHY - THE QUINTESSENCE OF THE ART OF MEDICINE, Medicina Clinica, 106(2), 1996, pp. 78-79
Authors:
LADERO JM
AGUNDEZ JAG
RODRIGUEZLESCURE A
DIAZRUBIO M
BENITEZ J
Citation: Jm. Ladero et al., RSAI POLYMORPHISM AT THE CYTOCHROME P4502E1 LOCUS AND RISK OF HEPATOCELLULAR-CARCINOMA, Gut, 39(2), 1996, pp. 330-333
Authors:
BENITEZ J
AGUNDEZ JAG
LADERO JM
RODRIGUEZLESCURE A
DIAZRUBIO M
Citation: J. Benitez et al., RSAI POLYMORPHISM AT THE CYP2E1 LOCUS AND RISK OF PRIMARY LIVER-CANCER, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 21-21
Authors:
MARTINEZ C
AGUNDEZ JAG
OLIVERA M
MARTIN R
LADERO JM
BENITEZ J
Citation: C. Martinez et al., LUNG-CANCER AND MUTATIONS AT THE POLYMORPHIC NAT2 GENE LOCUS, Pharmacogenetics, 5(4), 1995, pp. 207-214
Authors:
LADERO JM
BENITEZ J
SERRANO M
GARCIAPAREDES J
DIAZRUBIO M
Citation: Jm. Ladero et al., DEBRISOQUINE OXIDATION POLYMORPHISM IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL-DISEASE, Annals of medicine, 27(5), 1995, pp. 555-558
Authors:
AGUNDEZ JAG
LEDESMA MC
BENITEZ J
LADERO JM
RODRIGUEZLESCURE A
DIAZRUBIO E
DIAZRUBIO M
Citation: Jag. Agundez et al., CYP2D6 GENES AND RISK OF LIVER-CANCER, Lancet, 345(8953), 1995, pp. 830-831
Authors:
AGUNDEZ JAG
LADERO JM
OLIVERA M
ABILDUA R
ROMAN JM
BENITEZ J
Citation: Jag. Agundez et al., GENETIC-ANALYSIS OF THE ARYLAMINE N-ACETYLTRANSFERASE POLYMORPHISM INBREAST-CANCER PATIENTS, Oncology, 52(1), 1995, pp. 7-11
Authors:
AGUNDEZ JAG
LEDESMA MC
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., PREVALENCE OF CYP2D6 GENE DUPLICATION AND ITS REPERCUSSION ON THE OXIDATIVE PHENOTYPE IN A WHITE-POPULATION, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 265-269
Authors:
AGUNDEZ JAG
JIMENEZJIMENEZ FJ
LUENGO A
BERNAL ML
MOLINA JA
AYUSO L
VAZQUEZ A
PARRA J
DUARTE J
CORIA F
LADERO JM
ALVAREZ JC
BENITEZ J
Citation: Jag. Agundez et al., ASSOCIATION BETWEEN THE OXIDATIVE POLYMORPHISM AND EARLY-ONSET OF PARKINSONS-DISEASE, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 291-298
Authors:
AGUNDEZ JAG
ARROYO R
LEDESMA MC
MARTINEZ C
LADERO JM
DEANDRES C
JIMENEZJIMENEZ FJ
MOLINA JA
ALVAREZCERMENO JC
VARELADESEIJAS E
GIMENEZROLDAN S
BENITEZ J
Citation: Jag. Agundez et al., FREQUENCY OF CYP2D6 ALLELIC VARIANTS IN MULTIPLE-SCLEROSIS, Acta neurologica Scandinavica, 92(6), 1995, pp. 464-467
Authors:
AGUNDEZ JAG
MARTINEZ C
OLIVERA M
LEDESMA MC
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., MOLECULAR ANALYSIS OF THE ARYLAMINE N-ACETYLTRANSFERASE POLYMORPHISM IN A SPANISH POPULATION, Clinical pharmacology and therapeutics, 56(2), 1994, pp. 202-209
Authors:
AGUNDEZ JAG
MARTINEZ C
LEDESMA MC
LADONA MG
LADERO JM
BENITEZ J
Citation: Jag. Agundez et al., GENETIC-BASIS FOR DIFFERENCES IN DEBRISOQUIN POLYMORPHISM BETWEEN A SPANISH AND OTHER WHITE-POPULATIONS, Clinical pharmacology and therapeutics, 55(4), 1994, pp. 412-417
Authors:
BENITEZ J
AGUNDEZ JAG
MARTINEZ C
OLIVERA M
LEDESMA MC
LOZANO L
LADERO JM
Citation: J. Benitez et al., MOLECULAR ANALYSIS OF THE ACETYLATION POLYMORPHISM IN A SPANISH POPULATION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 171-171
Authors:
AGUNDEZ JAG
MARTINEZ C
LADERO JM
LEDESMA MC
RAMOS JM
MARTIN R
RODRIGUEZ A
JARA C
BENITEZ J
Citation: Jag. Agundez et al., DEBRISOQUIN OXIDATION GENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER, Clinical pharmacology and therapeutics, 55(1), 1994, pp. 10-14